Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Complement markers Bf and C4 in multiple sclerosis].

R Fauchet, M Madigand, M Y Gueguen-Duchesne

    Revue Neurologique
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dysregulation of the CD4<sup>+</sup> T cells lineage differentiation in dyslipidemic patients and impact of lipoprotein-apheresis treatment: A case study.

    Atherosclerosis. Supplements·2017
    Same author

    Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells.

    Diabetologia·2010
    Same author

    [Treatment of spontaneous intracranial hypotension by epidural saline infusion].

    Revue neurologique·2008
    Same author

    [Hepatitis C with cryoglobulinemia associated with Guillain-Barre syndrome].

    Presse medicale (Paris, France : 1983)·2001
    Same author

    Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.

    Journal of virology·2001
    Same author

    HLA-DMA alleles are possible new markers of rheumatoid arthritis: study of a Corsican group.

    Experimental and clinical immunogenetics·1999
    Same journal

    Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

    Revue neurologique·2026
    Same journal

    Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

    Revue neurologique·2026
    Same journal

    Neuro-Whipple presenting as autoimmune encephalitis.

    Revue neurologique·2026
    Same journal

    Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

    Revue neurologique·2026
    Same journal

    Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

    Revue neurologique·2026
    Same journal

    Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

    Revue neurologique·2026
    See all related articles

    The study found that the BfSS genotype is more common in multiple sclerosis patients, especially those without known risk markers like B7 and DR2. This suggests a closer genetic link to the Bf locus than previously thought.

    Area of Science:

    • Immunogenetics
    • Human Genetics
    • Neurology

    Context:

    • Multiple sclerosis (MS) has known associations with human leukocyte antigen (HLA) markers, including B7 and DR2.
    • The complement system's Factor B (Bf) and complement component 4 (C4) allotypes are also genetically linked to chromosome 6, suggesting their potential relevance in MS.
    • Previous research has identified specific HLA associations, but the role of other chromosome 6 markers like Bf and C4 requires further investigation.

    Purpose:

    • To investigate the association of Bf and C4 allotypes with multiple sclerosis (MS).
    • To determine if specific Bf and C4 genotypes are over-represented in an MS patient cohort.
    • To explore the relationship between Bf/C4 markers and known HLA risk factors (B7, DR2) in MS.

    Summary:

    Related Experiment Videos

  • A study of 50 unrelated patients for Bf markers and 41 for C4A/C4B markers revealed an over-representation of the Bf allotype S and the homozygous BfSS genotype in multiple sclerosis patients.
  • The BfSS homozygote was found to be significantly more frequent in patients lacking the B7 and/or DR2 risk markers.
  • No correlation was found between Bf or C4 markers and the disease's clinical course (remittent or progressive). Preliminary C4 data are still being analyzed.

    • Impact:

    • The findings reinforce the presence of a genetic component contributing to multiple sclerosis susceptibility.
    • The results suggest that the gene conferring susceptibility to MS may be located closer to the Bf locus than the DR locus on chromosome 6.
    • This research provides new insights into the complex genetic architecture of multiple sclerosis, potentially guiding future genetic association studies.